The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: fludarabine phosphate     Quarter: 2016Q3

Total Records: 134     Number of Pages: 7

DRUGNAME PT EventCount
FLUDARABINE PHOSPHATE. Second primary malignancy 1
FLUDARABINE PHOSPHATE. Shock 1
FLUDARABINE PHOSPHATE. Sinusitis 1
FLUDARABINE PHOSPHATE. Skin infection 1
FLUDARABINE PHOSPHATE. Skin mass 1
FLUDARABINE PHOSPHATE. Staphylococcal bacteraemia 1
FLUDARABINE PHOSPHATE. Status epilepticus 1
FLUDARABINE PHOSPHATE. Swelling 1
FLUDARABINE PHOSPHATE. Tardive dyskinesia 1
FLUDARABINE PHOSPHATE. Toxic leukoencephalopathy 1
FLUDARABINE PHOSPHATE. Tremor 1
FLUDARABINE PHOSPHATE. Vascular access complication 1
FLUDARABINE PHOSPHATE. Visual field defect 1
FLUDARABINE PHOSPHATE. Vomiting 1

Total Records: 134     Number of Pages: 7